CGEM vs PH · $830.3M cap vs P/E 28, rev $19.85B
Cullinan Oncology LLC (CGEM) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
CGEM currently screens at market cap $830.3M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the CGEM and PH stock pages for the full models.
Not investment advice.